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Abstract 
Background: Human gnathostomiasis is a food‑borne zoonosis. Its etiological agents are the third‑stage larvae of 
Gnathostoma spp. Human gnathostomiasis is often reported in developing countries, but it is also an emerging dis‑
ease in developed countries in non‑endemic areas. The recent surge in cases of human gnathostomiasis is mainly due 
to the increasing consumption of raw freshwater fish, amphibians, and reptiles.
Methods: This article reviews the literature on Gnathostoma spp. and the disease that these parasites cause in 
humans. We review the literature on the life cycle and pathogenesis of these parasites, the clinical features, epidemi‑
ology, diagnosis, treatment, control, and new molecular findings on human gnathostomiasis, and social‑ecological 
factors related to the transmission of this disease.
Conclusions: The information presented provides an impetus for studying the parasite biology and host immunity. 
It is urgently needed to develop a quick and sensitive diagnosis and to develop an effective regimen for the manage‑
ment and control of human gnathostomiasis.
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Background
Human gnathostomiasis, a food-borne zoonosis, is 
caused by the third-stage larvae  (L3) of Gnathostoma spp. 
[1]. Humans are infected by these nematodes by consum-
ing raw or undercooked fish, frogs, snakes or poultry that 
contain the  L3 [2]. The most common clinical signs and 
symptoms of the disease are migratory cutaneous swell-
ings and eosinophilia. In severe cases,  L3 also invade 
internal organs and tissues such as the liver, eyes, nerves, 
spinal cord and brain, which can result in blindness, 
nerve pain, paralysis, coma and even death [3].
The first human case of gnathostomiasis was reported 
from Thailand in 1889, and was attributed to infection 
by Cheiracanthus siamensis (Levinseen 1889). Shortly 
afterwards, Leiper (1891) found that C. siamensis was 
morphologically identical to Gnathostoma spinigerum, 
and thus considered the former a synonym of the latter. 
However, the life cycle of G. spinigerum was not eluci-
dated until 1936 [4]. To date, approximately 5000 cases of 
human gnathostomiasis have been reported worldwide, 
mainly from endemic areas in Japan and China, Thailand 
and other parts of Southeast Asia, Mexico, and Colombia 
and Peru in South America [1, 3]. Gnathostomiasis has 
also been reported, albeit infrequently, in travelers from 
developed countries who have visited endemic areas [3, 
5–8]. Furthermore, autochthonous gnathostomiasis has 
been reported in several non-endemic countries [9–12]. 
Therefore, human gnathostomiasis is considered an 
emerging global zoonosis [3, 13].
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The increase in reports of human gnathostomiasis may 
be due to changes in eating habits as a result of improved 
living standards, and also in improvements in health 
care systems for disease reporting [14]. The eradication 
of gnathostomiasis is challenging because of the world-
wide distribution of Gnathostoma spp. and increasing 
demand for exotic dishes such as marinated or raw fish 
[1, 14, 15]. Therefore, an effective prevention and con-
trol strategy should ideally be implemented for this dis-
ease. Here, we comprehensively review several aspects of 
human gnathostomiasis and discuss future prospects for 
the improvement of public perception of the importance 
of this parasitic disease.
Gnathostoma spp. and their life cycles
A gnathostome nematode was first discovered in 1836 in 
the stomach of a young tiger that had died of aortic rup-
ture at London Zoo [16]. Since then, Gnathostoma spp. 
(Nematoda: Gnathostomatidae) have been determined to 
be the etiological agents of human gnathostomiasis [17]. 
Among the 12 species in the genus, at least five, G. binu-
cleatum, G. doloresi, G. hispidum, G. nipponicum and G. 
spinigerum, cause human disease [18, 19]. The species 
most frequently found in humans and most widely dis-
tributed around the world is G. spinigerum; G. binuclea-
tum is found in the Americas [1]. Sporadic cases caused 
by G. doloresi, G. hispidum, and G. nipponicum have 
been documented in Asia [20–23].
Gnathostome eggs are oval in shape and have a mucoid 
plug at one or both ends, depending on the species 
[24]. The early  L3  (EL3) and the advanced  L3  (AdL3) of 
G. spinigerum in the second intermediate host usually 
measure 0.85–1.38 in length × 0.10–0.15 mm in diam-
eter and 2.30–4.40 in length × 0.25–0.43 mm in diam-
eter, respectively.  AdL3 have a characteristic head bulb 
of 93 × 221 μm on average, which often bears four rows, 
and occasionally five rows, of hooklets, a long muscular 
esophagus 0.63–1.22 mm in length and two pairs of cer-
vical sacs 0.33–0.75 mm in length.
Gnathostoma nematodes require two intermediate 
hosts and one definitive host to complete their life cycles 
(Fig. 1). In general, the adult worms live and spawn in a 
tumor-like mass in the stomach of the definitive host (e.g., 
cat, tiger, leopard or dog in the case of G. spinigerum). 
The eggs are released in the host’s feces into the environ-
ment, where they develop and hatch into the  first-stage 
larvae  (L1) in freshwater within 7  days at 28  °C.  L1 are 
then ingested by the first intermediate host, freshwater 
copepods (usually of the genera Cyclops, Eucyclops and 
Mesocyclops), where they develop into the second-stage 
larvae  (L2). When the infected copepods are consumed 
by the second intermediate host such as a fish or tadpole, 
 L2 migrate into the new host’s muscular tissue where 
they develop into  L3. If  L3 in the second intermediate 
host, transport or paratenic host are ingested by a defini-
tive host (e.g., dogs, cats, pigs or weasel), they migrate to 
the liver and the abdominal cavity after penetrating the 
gastric wall. Four weeks later they return to the gastric 
wall [1] and develop into adults. This development from 
L3 to adult usually takes 6-8 months. The definitive host 
starts to excrete the parasite eggs into the environment 
in its feces approximately 8 to 12 months after ingestion 
of  L3 [25, 26]. When  L3 are eaten by paratenic hosts such 
as frogs, snakes, birds and mammals including humans, 
they migrate through their tissues and remain encysted 
in their muscles.
Human gnathostomiasis can occur through three 
modes of transmission: oral, transplacental and skin 
wounds. However, this parasitic disease is mainly caused 
by the ingestion of raw or undercooked meat of interme-
diate hosts, such as fish, frogs, snakes or poultry, which 
contains  L3 [27]. Oral infection can also occur through 
drinking water contaminated with infected copepods 
[28]. Transplacental infection only occurs in pregnant 
women with a heavy infection of gnathostome larvae, 
which is rare [29].  L3 harbored in the infected meat of 
intermediate hosts can penetrate the skin of humans, 
particularly through wounds [30].
Pathogenesis and clinical presentation
Humans are not definitive hosts of Gnathostoma spp., 
and  L3 cannot mature into adults in them [31].  L3 can, 
however, cause damage to their tissues and/or organs by 
inducing host reactions, like inflammation and allergy, 
when they migrate and secrete excreta and toxins [32].  L3 
may cause damage to vital organs and the central nervous 
system (CNS), resulting in detrimental outcomes includ-
ing the sudden death of an infected individual [33, 34]. 
The larvae release excretory-secretory products (ES) with 
divergent functions that contribute to different parasite 
behaviors including cutaneous and visceral larva migrans 
[35, 36]. Recent studies have demonstrated that G. spini-
gerum ES antigens modulate monocyte function via 
inhibition of Fc gamma receptor I expression, and trig-
ger apoptosis of the peripheral blood mononuclear cells 
mainly via the extrinsic pathway [37, 38].
Gnathostoma larvae can migrate to the skin though 
subcutaneous tissue, and penetrate other tissues and 
organs including the eyes, ears, breasts, lungs, gastro-
intestinal tract, thoracic spinal cord, genitourinary sys-
tem and CNS [8, 39]. Clinical features mostly manifest 
as cutaneous and visceral migrans, depending on which 
parts of the body have been invaded. Within 1 or 2 days 
of ingestion, a Gnathostoma larva migrates through the 
gastrointestinal tract wall and the liver. Patients may 
develop systemic symptoms and signs such as fever, 
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anorexia, nausea, vomiting, abdominal pain, joint pain 
etc., which may last for more than 2  weeks. Cutaneous 
gnathostomiasis involves migrating lumps, which are 
the most important features in diagnosis of the disease. 
Clinical manifestations of the various organs infected by 
Gnathostoma spp. differ. A significant increase in eosino-
phils is common and can be used as a basis for auxiliary 
diagnosis [40]. The most common form of infection is 
larval migration within skin tissues, which causes a great 
amount of pain and lasts for 3–4 weeks. The pathogen-
esis of gnathostomiasis remains largely unknown. Never-
theless, it is plausible that the symptoms and signs of the 
disease are due to the mechanical damage caused by lar-
val migration, the inflammation and infection that is sec-
ondary to the mechanical damage, the combined effects 
of reactions to larval ES and the activation of an immune 
response in the host.
Cutaneous gnathostomiasis
Cutaneous gnathostomiasis, which is always accompa-
nied by nodular migratory panniculitis [40], is the most 
common clinical manifestation of human gnathosto-
miasis. The larvae spread throughout the body (limbs, 
face, back, abdomen, armpits, breasts etc.) by migrating 
through the epidermis, dermis and subcutaneous tissue, 
causing cutaneous larva migrans and resulting in skin 
irritation, pain and pruritus [41]. Reports of six cases of 
cutaneous gnathostomiasis noted that it takes an aver-
age of 12 days for the condition to be diagnosed and for 
a patient to start treatment [42, 43]. In these cases, lar-
vae were found in the dermis and subcutaneous tissue 
by pathological examination of the skin lesions, which 
were infiltrated with numerous eosinophils along with 
low numbers of lymphocytes and neutrophils.  L3 can sur-
vive in the human body for a very long period of time; 
episodes of swelling may become brief and less intense, 
and symptoms may recur intermittently for more than 10 
Fig. 1 Life cycle of Gnathostoma. L1 First‑stage larva,  L2 second‑stage larva,  L3 third‑stage larva. Adapted from the Centers for Disease Control and 
Prevention (CDC) DPDx website (https ://www.cdc.gov/dpdx/gnath ostom iasis /index .html)
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years in untreated patients. Cutaneous gnathostomiasis 
should be suspected in a patient with creeping eruption, 
migratory swellings, a skin abscess or nodules [44].
Visceral gnathostomiasis
Gnathostoma larvae, which are highly invasive, can 
migrate throughout various internal organs, resulting 
in a wide range of symptoms and signs that can affect 
almost any part of the body. In the visceral disease, lar-
vae may cause intermittent symptoms for a long period 
of time or, without proper treatment, until the host’s 
death [1].
Ocular manifestations
Gnathostoma larvae can invade the eyes, leading to exter-
nal and internal ocular lesions with inflammation, and 
other symptoms and signs such as subarachnoid hemor-
rhage, and even permanent vision loss [34, 45]. Clinical 
manifestations such as occasional eyelid edema, con-
junctival pain and conjunctival erythema have also been 
reported [46]. Larvae in the eyes can be visualized, and 
are generally found in the anterior chamber. With surgi-
cal removal of larvae, visual performance can be recov-
ered completely, but optic neuropathy can occur leading 
to permanent blindness [47, 48].
Auricular manifestations
L3 can damage the inner ear leading to tinnitus, dizzi-
ness, hearing loss and other symptoms.
Pulmonary manifestations
Clinical manifestations in patients with pulmonary 
involvement include fever, cough, chest pain, nodu-
lar densities and pneumothorax, mostly accompanied 
by complicated pleural effusion [49]. Peripheral blood 
eosinophils in patients with pulmonary manifestations 
were found to be significantly increased [29]. Lung can-
cer patients infected with Gnathostoma spp. suffered 
repeated fevers, cough, chest tightness and other respira-
tory non-specific symptoms [1].
Gastrointestinal manifestations
Gastrointestinal manifestations of gnathostomiasis in 
humans include sharp abdominal pain, anorexia, vom-
iting, and indigestion as the larvae invade the stomach 
wall, which causes a large area of gastric mucosal inflam-
matory congestion and can result in a gastric ulcer or 
gastric perforation, and even acute right iliac fossa pain 
[1].
Genitourinary manifestations
Larvae can pass through bladder tissue into the urine, 
and symptoms of this may include hematuria, the sen-
sation of a foreign body in the urine, etc. Urinary tract 
disease is rare [50–52].
CNS manifestations
Invasion of the CNS by Gnathostoma  L3 causes neu-
rognathostomiasis [53], the severest form of visceral 
disease. Patients mainly present with symptoms of 
radiculomyelitis or radiculomyeloencephalitis, eosino-
philic meningitis or meningoencephalitis, subarachnoid 
and even intracerebral hemorrhage [54–56]. Human 
neurognathostomiasis has a long history, with the first 
case reported in 1949 and the first pathologic evidence 
documented in 1967 [57, 58]. Since then, the detection 
of neurognathostomiasis has increased steadily due to 
improved diagnostic techniques.
Gnathostoma  L3 are highly invasive, and migrate 
by releasing various molecules, such as cysteine pro-
teases and matrix metalloproteinases (MMPs) into the 
invaded micro-environment to promote their penetra-
tion and invasion of organs [59, 60]. Larvae invade the 
CNS directly through the loose connective tissues of the 
neural foramina of the skull base, and the intervertebral 
foramina of the spine and vessels [61]. Radiculomyelitis 
can be caused by larvae entering the nerve roots of the 
spinal cord [62]. Migration of the larvae within the CNS 
can also cause mechanical injury, parenchymal damage 
and subarachnoid hemorrhage [63]. The salient symp-
toms and signs of neurognathostomiasis are the sudden 
onset of severe radicular pain with headache followed 
by loss of function of the cranial nerves and paralysis 
of the extremities, or quadriparesis with bladder dys-
function; the initial pain is characteristically followed 
by degrees of paralysis, ranging from weakness to thor-
ough paralysis of one to all four limbs [56, 64]. Further 
migration of the larvae within the CNS may lead to a 
multiplicity of rapidly progressing lesions beyond the 
extent of cerebral edema [1].
Direct mechanical damage to the CNS can also occur, 
as the relatively large  L3, averaging 3–4 mm in length, 
can migrate through neural or vascular tissue [65]. Lar-
vae burrowing through a cerebral arteriole may cause 
subarachnoid hemorrhage. The universal presence of 
eosinophilic pleocytosis indicates that inflammatory 
responses to larval invasion could lead to further tissue 
destruction [64].
Should migrating larvae invade vital structures in the 
brain stem, death can occur after several days following 
the onset of symptoms [56]. High-resolution magnetic 
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resonance imaging (MRI) can be used to image the 
tracks of Gnathostoma  L3, and greatly increases the 
accuracy of diagnosis of neurognathostomiasis [66].
Epidemiology
Gnathostoma spp. have a worldwide geographical dis-
tribution. About 5000 cases of human gnathostomia-
sis have been reported worldwide since the first one 
was described in Thailand in 1889. Gnathostomiasis is 
endemic in Japan and Thailand [1], and has been sporadi-
cally reported in numerous countries around the world 
(Fig. 2).
Five Gnathostoma species have been found to infect 
humans. G. spinigerum is commonly found in China, 
India, Japan and Southeast Asia; G. hispidum is found 
in Asia, Australia and Europe; G. doloresi is found in 
Southeast Asia; G. nipponicum is distributed in Korea 
and Japan [1]; and G. binucleatum is found in Mexico and 
some South American countries.
In Japan, 3182 cases of human gnathostomiasis were 
reported from 1911 to 1995, with 103 cases in which a 
Gnathostoma worm was detected [22, 54, 67–74]. Sev-
enty three cases were reported from 1996 to 2012, with 
the detection of  L3 in 29 cases (personal communication, 
unpublished data). In Thailand, there have been 1079 
recorded cases of human gnathostomiasis. The seroprev-
alence of Gnathostoma in humans was 62.5% (531/849) 
in Bangkok, Thailand between 2000 and 2005 [75]. The 
high prevalence of gnathostomiasis in this population 
might be partly due to the local custom of eating raw fish 
[75]. In China, the first case of human gnathostomiasis 
was reported in Xiamen, Fujian province in 1919. Eighty-
six cases (83 of which were caused by G. spinigerum, two 
by G. hispidum and one by G. doloresi) were reported 
between 1918 and 2014, mostly in southern and eastern 
China [41, 67, 68, 76–80]. Among these cases of human 
gnathostomiasis, more than 90% were due to the inges-
tion of raw or undercooked food (mostly fish, including 
eels and loach, but also frogs and snakes) [81].
Social‑ecological status
Although the presence of intermediate hosts is necessary 
for the endemism of gnathostomiasis, dietary habits are a 
key factor in its transmission. As mentioned earlier, eels, 
loaches, frogs and snakes, considered delicacies by some 
ethnic populations, are the most important second inter-
mediate hosts of Gnathostoma spp. [1]. An increasing 
number of people can afford these delicacies due to the 
improvement of living standards. Freshwater fish (includ-
ing eels and loaches), either raw or marinated in lemon 
juice, such as in sushi, sashimi and ceviche, are very 
popular food items worldwide [82, 83]. In many coun-
tries and regions, offering raw fish to guests is deemed a 
hospitable gesture. Many people mistakenly believe that 
raw fish are highly nutritious and that the  L3, if present 
within them, can be killed by the concurrent consump-
tion of alcohol or hot spices. It is also known that smok-
ing or pickling may not always be effective in killing  L3 
[1]. Adequate cooking is the most effective way of ensur-
ing that the larvae are killed, although freezing infected 
food at −20 °C for 3–5 days is also effective [1].
A high demand for exotic foods such as eel, loach, frog 
and snake has led to the rapid expansion of aquaculture 
around the world, and rivers, lakes and water reservoirs 
are now widely used to increase their cultivation [18]. 
Pigs are definitive hosts of Gnathostoma spp. Many small 
pig farms in developing countries are purposely built so 
that the swine feces end up in a pond/river/lake as feed 
for aquatic animals. However, pigs may be infected with 
Gnathostoma spp., in which case the eggs in their feces 
can act as the source of infection of intermediate hosts 
[84].
Diagnosis
The diagnosis of human gnathostomiasis is based on 
clinical symptoms and signs (intermittent subcutane-
ous or cutaneous migratory swelling), an elevated blood 
eosinophil level and a relevant exposure history (liv-
ing in or traveling to endemic regions; ingesting raw or 
undercooked fish, frog or chicken) [85]. Subcutaneous 
gnathostomiasis commonly presents as a single nodule; 
in contrast, multiple nodules often exist in other para-
sitic infections such as sparganosis and cysticercosis 
[86]. A final diagnosis of gnathostomiasis can be estab-
lished upon surgical removal of  L3 or identification of 
the worms in a tissue specimen along with eosinophilia 
[8, 46, 87]. The accurate identification and differentia-
tion of various Gnathostoma species have traditionally 
been based on morphological features [88]. However, the 
genus Gnathostoma includes 12 different species, five of 
which infect humans, that are virtually indistinguishable 
based on morphology, particularly at the larval and/or 
egg stages, which raises questions about Gnathostoma 
taxonomy [89].
Molecular techniques provide a definitive alternative 
approach to morphological identification and differen-
tiation of Gnathostoma species. PCR-based approaches 
such as amplicon sequencing are a rapid and sensitive 
means of identification, and can be used for the phyloge-
netic analysis of different Gnathostoma species. The most 
commonly targeted genetic markers, namely nuclear 
small subunit ribosomal RNA (rRNA), internal tran-
scribed spacer (ITS) regions of nuclear ribosomal DNA 
(rDNA) and the mitochondrial (mt) cytochrome  c  oxi-
dase subunit 1 (cox1) gene, have been used to study 
genetic variation in Gnathostoma [90–93]. PCR-coupled 
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sequencing and bioinformatics methods have also been 
used to identify and differentiate Gnathostoma in fixed 
and paraffin-embedded tissues, and can be used for the 
reappraisal of individual cases [94].
Gnathostomiasis can also be diagnosed using antigen-
specific immunoglobulin G (IgG) antibodies, although 
the detection of Gnathostoma spp. larvae is the gold 
standard for its diagnosis. An enzyme-linked immuno-
sorbent assay (ELISA) for  L3 IgG antibodies has been 
developed. However, its sensitivity and specificity have 
been shown to be poor, i.e. 59–87% and 79–96%, respec-
tively [95]. Some studies reported a significant improve-
ment in the diagnosis of human gnathostomiasis, 
although the  IgG2 antibody showed cross-reactivity with 
several other nematode species [96]. Currently, an inabil-
ity to accurately identify the infecting species of Gna-
thostoma is a major limitation in the diagnosis of human 
gnathostomiasis. Serological tests often show limited 
species identification due to antigenic cross-reactivity 
between species. A recent study indicated that recombi-
nant MMPs of G. spinigerum can be used for the serodi-
agnosis of neurognathostomiasis [97].
Neuroimaging is non-specific and non-confirmatory, 
but can be used to complement serological tests to pro-
vide a presumptive diagnosis of human gnathostomiasis. 
Medical imaging techniques such as CT, MRI and ultra-
sonography can be used to assist the clinical diagnosis 
of patients with visceral disease [98–100]. MRI is supe-
rior to CT in the neuroimaging of cerebral larva migrans 
caused by Gnathostoma spp. A presumptive diagnosis 
of gnathostomiasis in cases where larvae have not been 
recovered can be reached by a combination of positive 
neuroimaging and immunoblot [60]. However, accurate 
diagnosis by imaging heavily depends upon infection 
intensity. Immunochromatographic test kits are promis-
ing diagnostic tools for rapid clinical diagnosis at the site 
of care and also for epidemiological surveys [101].
Treatment and control
There is no effective non-invasive treatment for human 
gnathostomiasis, and the surgical removal of larvae is 
considered the most effective treatment for this disease 
[1]. However, surgical removal is only feasible in cases 
of cutaneous or other types of superficial migration. For 
most cases of visceral gnathostomiasis, surgical removal 
is impracticable if not impossible. In these cases, vari-
ous drugs (thiabendazole, praziquantel, metronidazole, 
diethylcarbamazine, and quinine) have been tested, but 
have shown no obvious efficacy [102].
Albendazole is the drug of first choice for human gna-
thostomiasis. A recommended dose of 400  mg twice 
a day for 21 days resulted in a cure rate of > 90% [103]. 
Ivermectin has similar therapeutic efficacy to that 
reported for albendazole [104], and has been shown to be 
effective at either 0.2 mg/kg as a single dose or at 0.1 mg/
kg administered on 2 consecutive days. Corticosteroids 
may be administered alone (prednisolone, 60 mg/day 
for 7 days), and cause the larvae to migrate and then die 
naturally [51]. Nevertheless, steroids should be used with 
Fig. 2 Map of countries with reported cases of gnathostomiasis
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caution in cases of ocular or CNS gnathostomiasis due to 
their potential to cause further larval migration.
Initial chemotherapy is usually unsuccessful, as the 
majority of patients relapse and then require a second or 
even a third course of albendazole or ivermectin therapy. 
Relapses are often heralded by the appearance of periph-
eral eosinophilia [105]. However, in a few cases, albenda-
zole or ivermectin has been used as an initial treatment 
with successful outcomes. A recent report by Gui et  al. 
[106] showed that albendazole at 400 mg/day for 10 
days successfully cured two patients with pulmonary 
gnathostomiasis.
New insights into human gnathostomiasis 
from the “omics” sciences
The complete elucidation of four Gnathostoma mt 
genomes was an important step towards a better under-
standing of these parasites, and the disease that they 
cause, at the molecular level. Genomic data could prove 
useful for the reassessment of phylogenetic relationships, 
and for the development of next-generation diagnostics 
and therapeutic interventions. Complete mt genomes 
have been elucidated for G. spinigerum (14,079 bp) [107], 
Gnathostoma sp. (14,391 bp), G. nipponicum (14,093 bp) 
[108], and G. doloresi from China (13,809 bp) and Japan 
(13,812 bp) [109]. These mt genomes encompass 36 
genes including two rRNA genes, 22 transfer RNA genes 
and 12 protein-coding genes with the atp8 gene missing 
[107–109]. The inference of amino acid sequences from 
mt genome sequences is necessary for the systematic 
analysis of the relationships between Gnathostoma and 
other nematodes at the molecular level. Concatenated 
mt proteomic datasets have been shown to be very useful 
for re-examining the systematic relationships of different 
nematode groups [110–115]. Because of the strong phy-
logenetic signals and statistical support in phylogenetic 
trees generated from mt proteomic datasets of members 
of the suborder Spirurina [34, 116], it is now considered 
timely to examine the phylogenetic relationships of many 
spirurine nematodes. Molecular tools that use genetic 
markers such as rDNA ITS sequences and mt cox1 have 
been examined for their application to the clinical diag-
nosis of Gnathostoma infection [91, 93]. Sequence heter-
ogeneity in ITS rDNA can be high in individual nematode 
specimens [117], and the protein-coding genes of the mt 
genome are reasonably predicted to be better suited for 
this type of analysis [118]. This can be achieved by using 
PCR-coupled single-strand conformation polymorphism 
and DNA sequencing [119]. This technique has already 
been applied, on a small scale, to G. spinigerum [92]. A 
comparative study of DNA sequences indicated that the 
mt cox1 gene can be used as a genetic marker for the 
identification and differentiation of Gnathostoma species 
[93]. Mt cox1 sequences showed a relatively high degree 
of genetic variability (four distinct haplotypes) among 
G. spinigerum specimens from different host species 
(i.e. dogs, snakes and eels) and localities within Asia and 
Southeast Asia (i.e. China, Indonesia, Laos and Thai-
land) [120]. An assessment of the various haplotypes or 
genotypes of Gnathostoma and how they relate to differ-
ent clinical signs of gnathostomiasis in humans would be 
useful.
Proteomic analyses of G. spinigerum are increasingly 
recognized for their value in the study of parasite biol-
ogy and host-parasite interactions. Various biological and 
pathological functions of antigenic proteins of G. spini-
gerum have been identified, which include responses to 
stress, metabolic processes and energy generation, pro-
teolysis, cell skeleton formation, protein folding, oxida-
tion-reduction and carbohydrate ligand binding [121]. 
Immunoproteomic analysis has identified a number of 
antigenic proteins of G. spinigerum with potential as vac-
cine candidates for G. spinigerum infection.
Genome, developmental transcriptome and microRNA 
datasets constitute a collective resource for future inves-
tigations into the molecular biology, immunobiology, 
phylogenetics, epidemiology, population genetics and 
pathogenesis of Gnathostoma and/or gnathostomiasis. 
They should also be useful for the improvement of diag-
nostics and development of new drugs, including anthel-
mintics and vaccines [122]. Future studies should focus 
on: (i) sequencing and annotating the genome of G. spini-
gerum, and comparing it with those of other nematodes, 
with particular emphasis on excretory and secretory pro-
tein-encoding genes that are predicted to be involved in 
host invasion and parasite-host interactions; (ii) develop-
mental transcriptome or microRNA datasets, which may 
prove useful for a better understanding of the biology and 
physiology of Gnathostoma nematodes.
Conclusions and future directions
While soil-transmitted helminths have received much 
attention because of their major socioeconomic impacts 
[123], other types of helminths such as Gnathostoma spp. 
have been largely neglected. Despite the fact that epide-
miological studies of gnathostomiasis have been reported 
from many countries worldwide, gaps exist in our under-
standing of the epidemiology of Gnathostoma infection, 
and its zoonotic importance remains ill-defined. Com-
bined with the lack of any estimate of the global burden 
of gnathostomiasis, all of these factors serve to limit a 
proper assessment of the public health impact and bur-
den of gnathostomiasis.
Deciphering the genomes of Gnathostoma and their 
transcription will assist investigations into the immu-
nobiology of this genus, as well as provide a genetic 
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basis for the epidemiological study of these parasites. 
This will also facilitate studies on the biology, bio-
chemistry, and physiology of these parasites, and the 
molecular mechanisms involved in their ability to 
modulate or evade the host immune system [124–126]. 
MicroRNAs have been assessed for their diagnostic 
value in several nematode infections [127–129], and 
the identification of specific biomarkers for the diag-
nosis of gnathostomiasis is a promising direction for 
future investigations.
The public health importance of helminthic infec-
tions, including gnathostomiasis, has been seriously 
neglected worldwide. The devastating consequences of 
this include the persistence and ever-increasing num-
ber of cases of gnathostomiasis, and the corresponding 
heavy disease burden. Human gnathostomiasis is now 
considered an important food-borne parasitic zoono-
sis [15, 130]. Human beings are infected with Gnathos-
toma spp. mainly by consuming raw or undercooked 
food (fish, frogs, eel, poultry and snakes) that contains 
the parasite larvae. Dogs, cats, snakes, fish and birds all 
play important roles in the transmission of this disease. 
Recommended measures for the prevention and con-
trol of human gnathostomiasis primarily focus on edu-
cational campaigns in an effort to change eating habits. 
First, adequate cooking of potentially infected food is 
the safest way to ensure that larvae are killed, thereby 
preventing infection. Secondly, treating the definitive 
hosts, such as dogs and cats, with anthelmintics mini-
mizes the source of infection. Thirdly, public aware-
ness needs to be increased to promote a reduction in 
the hunting and sale of wildlife—especially wild birds, 
loaches, eels and snakes—for human consumption.
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